Market Snapshot
S&P Futures
4,132
Dow Futures
32,804
Nasdaq Futures
13,053.75
Quoin Pharmaceuticals, Ltd. (QNRX) stock declined over -1.25% intraday to trade at $5.52 a share on NASDAQ. The stock opened with a loss of -16.11% at $6.03 and touched an intraday high of $6.5, rising 4.35% against the last close of $5.29. The stock went to a low of $5.48 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-08-08 | $6.03 | $6.5 | $5.48 | $5.59 | 5,336,947 |
2022-08-05 | $6.58 | $7.1 | $4.33 | $5.29 | 16,255,400 |
2022-08-04 | $18.77 | $22 | $11.68 | $14.06 | 11,714,800 |
2022-08-03 | $4.33 | $28.11 | $4.17 | $19.8 | 29,178,900 |
2022-08-02 | $6.78 | $7.33 | $4.11 | $4.3 | 4,661,500 |
2022-08-01 | $4.29 | $4.29 | $3.58 | $3.85 | 167,000 |
2022-07-29 | $4.662 | $4.675 | $4.137 | $4.463 | 41,040 |
2022-07-28 | $5 | $5 | $4.5 | $4.613 | 46,560 |
2022-07-27 | $4.875 | $5 | $4.75 | $4.838 | 24,224 |
2022-07-26 | $5.162 | $5.375 | $4.75 | $4.775 | 28,656 |
Employees-
Beta1.58
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
Sector-
Industry-
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. It offers QRX003, a topical lotion to treat Netherton Syndrome; QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company was incorporated in 2018 and is based in Ashburn, Virginia.
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) stock price is $5.52 as of the last check on Monday, August 8. During the trading session, QNRX stock reached the peak price of $6.5 while $5.48 was the lowest point it dropped to.
The NASDAQ listed QNRX is part of - industry that operates in the broader - sector. Quoin Pharmaceuticals, Ltd. , a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases.
Dr. Michael Myers Ph.D.
Co-Founder, CEO & Chairman
Ms. Denise Carter
Co-Founder, COO & Director
Mr. Gordon Bruce Dunn J.D.
Chief Financial Officer
QNRX stock traded closed the last session at $5.59, which is -$0.07000000000000028 or -1.2522361359570713% lower than its previous close of $5.29. QNRX's current trading price is 56.15% lower than its 52-week high of $444 where as its distance from 52-week low of 3.58% is -98.74%.
Number of QNRX employees currently stands at -. QNRX operates from 42127 Pleasant Forest Court, Ashburn, VA 20148-7349, United States.
Official Webiste of $QNRX is: https://quoinpharma.com
QNRX could be contacted at QNRX operates from 42127 Pleasant Forest Court, Ashburn, VA 20148-7349, United States, or at phone #703 980 4182 and can also be accessed through its website.
QNRX stock volume for the day was 326,325 shares while in the previous session number of QNRX shares traded was 5,336,947 . The average number of QNRX shares traded daily for last 3 months was 1.19 Million.
The percentage change in QNRX stock occurred in the recent session was -1.2522361359570713% while the dollar amount for the price change in QNRX stock was -$0.07000000000000028.
In the recent session, the day high for QNRX stock was $6.5 while the low for QNRX stock touched on the day was $5.48.
The market value of QNRX currently stands at 9.95 Million with its latest stock price at $5.52 and 8.35 Million of its shares outstanding.